These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2662527)

  • 1. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3555. PubMed ID: 2662527
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of class I major histocompatibility complex antigens on hepatic allograft survival in rats: distribution of donor cells which express class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Ogawa M
    Transplant Proc; 1995 Feb; 27(1):540-2. PubMed ID: 7879091
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor major histocompatibility complex class I antigens.
    Oluwole SF; Chowdhury NC; Fawwaz R; James T; Hardy MA
    Transplant Proc; 1993 Feb; 25(1 Pt 1):299-300. PubMed ID: 8438308
    [No Abstract]   [Full Text] [Related]  

  • 4. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigens in rats.
    Yamaguchi Y; Miyanari N; Ichiguchi O; Akizuki E; Matsumura F; Matsuda T; Okabe K; Liang J; Ohshiro H; Mori K; Ogawa M
    Hepatology; 1998 Aug; 28(2):450-8. PubMed ID: 9696011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for MHC antigens in donor-specific blood transfusion for the inhibition of liver allograft rejection in the rat.
    Ishii E; Sumimoto R; Yamaguchi A
    Transplantation; 1992 Oct; 54(4):750-2. PubMed ID: 1412773
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of class I antigens in hyperacute rejection of hepatic allografts in rats.
    Knechtle SJ; Yamaguchi Y; Harland RC; Coundouriotis A; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3557. PubMed ID: 2662529
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: in situ splenic distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Jan; 60(1):216-23. PubMed ID: 8592417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat.
    Yamaguchi Y; Harland RC; Wyble C; Bollinger RR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):792-3. PubMed ID: 2650272
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of passenger leukocytes in the immunogenicity of intestinal and cardiac allografts in the rat.
    Gundlach M; Oluwole S; D'Agati V; Chabot J; Broelsch CE; Hardy MA
    Transplant Proc; 1992 Jun; 24(3):1131-2. PubMed ID: 1604552
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pretreatment with fetal liver fragment transplantation on survival of rat liver allograft.
    Fukuda Y; Ohdan H; Tashiro H; Ito H; Takebe K; Hagihara M; Shimura T; Tsuji K; Dohi K
    Transplant Proc; 1996 Jun; 28(3):1364-5. PubMed ID: 8658696
    [No Abstract]   [Full Text] [Related]  

  • 12. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ex vivo perfusion with anti-Ia monoclonal antibodies on rat cardiac allograft survival.
    Sone Y; Sakagami K; Orita K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):599-604. PubMed ID: 3547831
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 15. Permanent rat cardiac allograft survival induced by ultraviolet B-irradiated donor lymphocytes and peritransplant cyclosporine.
    Oluwole SF; Fawwaz RA; Reemtsma K; Hardy MA
    Surgery; 1988 Aug; 104(2):231-8. PubMed ID: 2969630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both L- and D-isomers of allotrap 2702 prolong cardiac allograft survival in mice.
    Gao L; Woo J; Buelow R
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):78-87. PubMed ID: 8820086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of protein micelles containing purified class I MHC antigen and a cytosolic preparation containing water soluble class I molecules on rat renal allograft survival.
    Foster S; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):375-6. PubMed ID: 2650152
    [No Abstract]   [Full Text] [Related]  

  • 18. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
    DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.